Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Complete Loss of Myelin protein zero (MPZ) in a patient with a late onset Charcot-Marie-Tooth (CMT).

Metabolic brain disease - 1 Aug 2023

Gharesouran Jalal, Hosseinzadeh Hassan, Naghiloo Ali, Ghafouri-Fard Soudeh, Hussen Bashdar Mahmud, Taheri Mohammad, Rezazadeh Maryam, Samadian Mohammad

Abstract excerpt

Charcot-Marie-Tooth (CMT) comprises a group of hereditary neuropathies with clinical, epidemiological, and molecular heterogeneity in which variants in more than 80 different genes have been reported. One of the important genes which cause 5% of all CMT cases is Myelin protein zero (P0, MPZ). Variants in this gene have been reported in association with different forms of CMT including classical CMT1, severe DSS...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Charcot-Marie-Tooth Disease
Share to Exons

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mutation

Share to Myelin P0 Protein

Share to Myelin Sheath

Share to Proteins

Source

Identifiers

PMID: 36952089
DOI: 10.1007/s11011-023-01201-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Complete Loss of Myelin protein zero (MPZ) in a patient with a late onset Charcot-Marie-Tooth (CMT).PMID 36952089Read ↗

Genetic and clinical spectrums in Korean Charcot-Marie-Tooth disease patients with myelin protein zero mutations.Semantic proximity Read ↗

Clinical phenotypes of different MPZ (P0) mutations may include Charcot-Marie-Tooth type 1B, Dejerine-Sottas, and congenital hypomyelination.Semantic proximity Read ↗

Genetic spectrum of Charcot-Marie-Tooth disease associated with myelin protein zero gene variants in Japan.Semantic proximity Read ↗

Myelin protein zero mutation-related hereditary neuropathies: Neuropathological insight from a new nerve biopsy cohort.Semantic proximity Read ↗

Navigating the Landscape of CMT1B: Understanding Genetic Pathways, Disease Models, and Potential Therapeutic Approaches.Semantic proximity Read ↗

Four novel mutations of the myelin protein zero gene presenting as a mild and late-onset polyneuropathy.Semantic proximity Read ↗

Upregulation of large myelin protein zero leads to Charcot-Marie-Tooth disease-like neuropathy in mice.Semantic proximity Read ↗

Rapid progression of late onset axonal Charcot-Marie-Tooth disease associated with a novel MPZ mutation in the extracellular domain.Semantic proximity Read ↗

Peripheral neuropathies caused by mutations in the myelin protein zero.Semantic proximity Read ↗

A novel MPZ gene mutation in exon 2 causing late-onset demyelinating Charcot-Marie-Tooth disease.Semantic proximity Read ↗

Mutation update for myelin protein zero-related neuropathies and the increasing role of variants causing a late-onset phenotypeSemantic proximity Read ↗

Clinical genetics of Charcot-Marie-Tooth disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.